{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T08:23:05Z","timestamp":1784622185117,"version":"3.55.0"},"reference-count":64,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Rising obesity has surged demand for weight loss interventions and body contouring procedures. The independent and combined effects of prior bariatric surgery (BS) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) on abdominoplasty outcomes remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To estimate the independent and combined associations of prior BS and recent GLP-1RA use with 90-day postoperative complications after abdominoplasty.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective cohort study used TriNetX network data on adults undergoing abdominoplasty (January 2004\u2013June 2025). Patients were grouped into no prior interventions, BS only, recent GLP-1RA use only, and both. Propensity score matching controlled for confounders and 90-day surgical complications were compared.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Included were 4776 patients with prior BS, 2253 recent GLP-1RA users, and 465 with both. Bariatric surgery increased the risks of hematomas (RR = 1.55; 95% CI 1.11-2.17) and seromas (RR = 1.55; 95% CI 1.19-2.02), lowered hypertrophic scarring (RR = 0.74; 95% CI 0.62-0.87) and systemic infections (RR = 0.78; 95% CI 0.64-0.93). Glucagon-like peptide-1 receptor agonists use heightened hypertrophic scarring risk (RR = 1.79; 95% CI 1.374-2.352), a finding confirmed in a sensitivity analysis against DPP-4 inhibitors (RR = 2.40). Glucagon-like peptide-1 receptor agonist use in BS patients increased wound dehiscence risk (RR = 1.92; 95% CI 1.12-3.38) and constitutional symptoms (RR = 1.69; 95% CI 1.164-2.461).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Bariatric surgery is associated with higher hematoma and seroma risks but lower hypertrophic scarring and systemic infections. Glucagon-like peptide-1 receptor agonists are independently associated with hypertrophic scarring risk. When combined, these interventions are associated with significant wound dehiscence and increased constitutional symptoms, underscoring the need for tailored perioperative management and preoperative counseling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Level of Evidence: 3 (Therapeutic)<\/jats:title>\n                    <jats:p>For image description, please refer to the figure legend and surrounding text.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/asj\/sjaf244","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T13:10:05Z","timestamp":1765458605000},"page":"728-736","source":"Crossref","is-referenced-by-count":2,"title":["Abdominoplasty After Bariatric Surgery and GLP-1 Receptor Agonists: Independent vs Combined Complication Risks"],"prefix":"10.1093","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4882-7109","authenticated-orcid":false,"given":"Adam","family":"Boukind","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Speller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5955-1734","authenticated-orcid":false,"given":"Saif","family":"Badran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"issue":"11","key":"2026061602131604300_sjaf244-B1","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1093\/asj\/sjaf131","article-title":"New contours, different risks: a 9-year comparison of trends and postoperative complications in patients undergoing aesthetic surgery with previous bariatric surgery vs glucagon-like peptide 1 receptor agonist use","volume":"45","author":"Khong","year":"2025","journal-title":"Aesthet Surg J"},{"issue":"10","key":"2026061602131604300_sjaf244-B2","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1016\/j.numecd.2021.06.018","article-title":"Efficacy and effects of bariatric surgery in the treatment of obesity: network meta-analysis of randomized controlled trials","volume":"31","author":"Cosentino","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"10","key":"2026061602131604300_sjaf244-B3","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nrgastro.2013.119","article-title":"Mechanisms underlying weight loss after bariatric surgery","volume":"10","author":"Miras","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7","key":"2026061602131604300_sjaf244-B4","doi-asserted-by":"publisher","first-page":"e5959","DOI":"10.1097\/gox.0000000000005959","article-title":"The impact of prior obesity surgery on bleeding after abdominal body contouring surgery","volume":"12","author":"Badran","year":"2024","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"5","key":"2026061602131604300_sjaf244-B5","doi-asserted-by":"publisher","first-page":"873","DOI":"10.17305\/bb.2023.8827","article-title":"The impact of prior obesity surgery on glucose metabolism after body contouring surgery: a pilot study","volume":"23","author":"Badran","year":"2023","journal-title":"Biomol Biomed"},{"issue":"9","key":"2026061602131604300_sjaf244-B6","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1111\/dom.13353","article-title":"Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials","volume":"20","author":"Ahr\u00e9n","year":"2018","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"2026061602131604300_sjaf244-B7","doi-asserted-by":"publisher","first-page":"348","DOI":"10.2106\/jbjs.24.00468","article-title":"Glucagon-like peptide-1 receptor agonists decrease medical and surgical complications in morbidly obese patients undergoing primary TKA","volume":"107","author":"Kim","year":"2025","journal-title":"J Bone Joint Surg"},{"issue":"1","key":"2026061602131604300_sjaf244-B8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.japh.2023.10.002","article-title":"Trends in glucagon-like peptide 1 receptor agonist use, 2014 to 2022","volume":"64","author":"Watanabe","year":"2024","journal-title":"J Am Pharm Assoc"},{"issue":"2","key":"2026061602131604300_sjaf244-B9","doi-asserted-by":"publisher","first-page":"292","DOI":"10.2337\/dc24-1678","article-title":"Efficacy of GLP-1 receptor agonists on weight loss, BMI, and waist circumference for patients with obesity or overweight: a systematic review, meta-analysis, and meta-regression of 47 randomized controlled trials","volume":"48","author":"Wong","year":"2025","journal-title":"Diabetes Care"},{"issue":"1","key":"2026061602131604300_sjaf244-B10","doi-asserted-by":"publisher","first-page":"e5516","DOI":"10.1097\/gox.0000000000005516","article-title":"Injectable weight loss medications in plastic surgery: what we know, perioperative considerations, and recommendations for the future","volume":"12","author":"O\u2019Neill","year":"2024","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"4","key":"2026061602131604300_sjaf244-B11","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/asj\/sjae241","article-title":"Semaglutide and postoperative outcomes in nondiabetic patients following body contouring surgery","volume":"45","author":"Lewis","year":"2025","journal-title":"Aesthet Surg J"},{"issue":"S2","key":"2026061602131604300_sjaf244-B12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/01.gox.0001113872.50021.01","article-title":"7. Impact of GLP-1 agonist weight loss drugs on surgical wound complications following plastic surgery procedures","volume":"13","author":"Lee","year":"2025","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"2026061602131604300_sjaf244-B13","doi-asserted-by":"publisher","first-page":"20420188231222367","DOI":"10.1177\/20420188231222367","article-title":"Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications","volume":"15","author":"Alharbi","year":"2024","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"2","key":"2026061602131604300_sjaf244-B14","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/jbcr\/irae189","article-title":"The emerging role of GLP-1 agonists in burn care: what do we know?","volume":"46","author":"Manasyan","year":"2025","journal-title":"J Burn Care Res"},{"key":"2026061602131604300_sjaf244-B15","doi-asserted-by":"publisher","first-page":"102475","DOI":"10.1016\/j.eclinm.2024.102475","article-title":"Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial","volume":"69","author":"Jensen","year":"2024","journal-title":"eClinicalMedicine"},{"issue":"6","key":"2026061602131604300_sjaf244-B16","doi-asserted-by":"publisher","first-page":"e2416775","DOI":"10.1001\/jamanetworkopen.2024.16775","article-title":"Bone health after exercise alone, GLP-1 receptor agonist treatment, or combination treatment","volume":"7","author":"Jensen","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026061602131604300_sjaf244-B17","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3389\/fendo.2020.00459","article-title":"The impact of post-bariatric abdominoplasty on secondary weight regain after Roux-en-Y gastric bypass","volume":"11","author":"Sandvik","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"15","key":"2026061602131604300_sjaf244-B18","doi-asserted-by":"publisher","first-page":"4315","DOI":"10.3390\/jcm11154315","article-title":"Post-bariatric plastic surgery: abdominoplasty, the state of the art in body contouring","volume":"11","author":"Sadeghi","year":"2022","journal-title":"J Clin Med"},{"issue":"1","key":"2026061602131604300_sjaf244-B19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/asj\/sjaa067","article-title":"Post-bariatric abdominoplasty: analysis of 406 cases with focus on risk factors and complications","volume":"41","author":"Schlosshauer","year":"2021","journal-title":"Aesthet Surg J"},{"issue":"7","key":"2026061602131604300_sjaf244-B20","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3390\/jpm14070681","article-title":"Experience in post-bariatric abdominoplasty for patients with significant weight loss: a prospective study","volume":"14","author":"Cuomo","year":"2024","journal-title":"J Pers Med"},{"issue":"5","key":"2026061602131604300_sjaf244-B21","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/asj\/sjaf029","article-title":"Postoperative outcomes in body contouring procedures following glucagon-like peptide-1 receptor agonist use: a 10-year analysis","volume":"45","author":"Liang","year":"2025","journal-title":"Aesthet Surg J"},{"issue":"2","key":"2026061602131604300_sjaf244-B22","doi-asserted-by":"publisher","first-page":"ooad035","DOI":"10.1093\/jamiaopen\/ooad035","article-title":"A global federated real-world data and analytics platform for research","volume":"6","author":"Palchuk","year":"2023","journal-title":"JAMIA Open"},{"issue":"6","key":"2026061602131604300_sjaf244-B23","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1007\/s11695-020-05200-0","article-title":"Decrease of dipeptidyl peptidase 4 activity is associated with weight loss after bariatric surgery","volume":"31","author":"Herz","year":"2021","journal-title":"Obes Surg"},{"issue":"25","key":"2026061602131604300_sjaf244-B24","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat Med"},{"issue":"6","key":"2026061602131604300_sjaf244-B25","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1007\/s11695-020-05213-9","article-title":"Association of bariatric surgery with clinical outcomes of SARS-CoV-2 infection: a systematic review and meta-analysis in the initial phase of COVID-19 pandemic","volume":"31","author":"Aminian","year":"2021","journal-title":"Obes Surg"},{"issue":"3","key":"2026061602131604300_sjaf244-B26","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1007\/s12020-025-04293-w","article-title":"GLP-1RA and the possible skin aging","volume":"89","author":"Paschou","year":"2025","journal-title":"Endocrine"},{"key":"2026061602131604300_sjaf244-B27","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.bjps.2024.05.045","article-title":"Plastic surgery amid a semaglutide epidemic: direction for future studies and service implications","volume":"95","author":"Ragsdale","year":"2024","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"5","key":"2026061602131604300_sjaf244-B28","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1007\/s11695-024-07175-8","article-title":"Glucagon-like peptide-1 receptor agonists in post-bariatric surgery patients: a systematic review and meta-analysis","volume":"34","author":"Dutta","year":"2024","journal-title":"Obes Surg"},{"key":"2026061602131604300_sjaf244-B29","doi-asserted-by":"publisher","first-page":"1337948","DOI":"10.3389\/fsurg.2024.1337948","article-title":"Abdominoplasty after massive weight loss. Safety preservation fascia technique and clinical outcomes in a large single series-comparative study","volume":"11","author":"Cannistr\u00e0","year":"2024","journal-title":"Front Surg"},{"issue":"15","key":"2026061602131604300_sjaf244-B30","doi-asserted-by":"publisher","first-page":"4350","DOI":"10.1007\/s00266-025-04975-w","article-title":"The impact of chemoprophylaxis and patients' demographics on bleeding after abdominal body contouring procedures","volume":"49","author":"Fadell","year":"2025","journal-title":"Aesthetic Plast Surg"},{"issue":"4","key":"2026061602131604300_sjaf244-B31","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1097\/01.prs.0000253445.76991.de","article-title":"Progressive tension sutures in the prevention of postabdominoplasty seroma: a prospective, randomized, double-blind clinical trial","volume":"120","author":"Andrades","year":"2007","journal-title":"Plast Reconstr Surg"},{"key":"2026061602131604300_sjaf244-B32","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.bjps.2025.04.004","article-title":"Scarpa fascia preservation abdominoplasty combined with precise liposuction for postpregnancy abdomen: a 10-year experience","volume":"105","author":"Tian","year":"2025","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"4","key":"2026061602131604300_sjaf244-B33","doi-asserted-by":"publisher","first-page":"sjw130","DOI":"10.1093\/asj\/sjw130","article-title":"Does the addition of progressive tension sutures to drains reduce seroma incidence after abdominoplasty? A systematic review and meta-analysis","volume":"37","author":"Jabbour","year":"2016","journal-title":"Aesthet Surg J"},{"issue":"11","key":"2026061602131604300_sjaf244-B34","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3349\/ymj.2023.0003","article-title":"Analysis of risk factors to predict occurrence and prognosis of postsurgical hypertrophic scar development: a review of 4238 cases","volume":"64","author":"Cho","year":"2023","journal-title":"Yonsei Med J"},{"key":"2026061602131604300_sjaf244-B35","doi-asserted-by":"publisher","first-page":"603187","DOI":"10.3389\/fimmu.2020.603187","article-title":"The roles of inflammation in keloid and hypertrophic scars","volume":"11","author":"Wang","year":"2020","journal-title":"Front Immunol"},{"issue":"12","key":"2026061602131604300_sjaf244-B36","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","article-title":"Chronic inflammation in the etiology of disease across the life span","volume":"25","author":"Furman","year":"2019","journal-title":"Nat Med"},{"issue":"2","key":"2026061602131604300_sjaf244-B37","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s11695-020-05001-5","article-title":"Decreased long-term respiratory infection risk after bariatric surgery: a comprehensive national cohort study","volume":"31","author":"Chen","year":"2021","journal-title":"Obes Surg"},{"issue":"6","key":"2026061602131604300_sjaf244-B38","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1007\/s11695-022-05975-4","article-title":"Impact of bariatric surgery on unplanned hospital admissions for infection","volume":"32","author":"Cundy","year":"2022","journal-title":"Obes Surg"},{"issue":"1","key":"2026061602131604300_sjaf244-B39","doi-asserted-by":"publisher","first-page":"e13317","DOI":"10.1111\/jar.13317","article-title":"Urinary tract infections amongst adults with intellectual disabilities with urinary incontinence","volume":"38","author":"Finlayson","year":"2025","journal-title":"J Appl Res Intellect Disabil"},{"key":"2026061602131604300_sjaf244-B40","doi-asserted-by":"publisher","first-page":"175628721881438","DOI":"10.1177\/1756287218814382","article-title":"Risk factors and predisposing conditions for urinary tract infection","volume":"11","author":"Storme","year":"2019","journal-title":"Ther Adv Urol"},{"issue":"3","key":"2026061602131604300_sjaf244-B41","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s11695-024-07066-y","article-title":"Comparison of histological skin changes after massive weight loss in post-bariatric and non-bariatric patients","volume":"34","author":"Hany","year":"2024","journal-title":"Obes Surg"},{"issue":"4","key":"2026061602131604300_sjaf244-B42","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1007\/s11695-020-05100-3","article-title":"Skin changes due to massive weight loss: histological changes and the causes of the limited results of contouring surgeries","volume":"31","author":"Rocha","year":"2021","journal-title":"Obes Surg"},{"issue":"2","key":"2026061602131604300_sjaf244-B43","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.eprac.2023.11.007","article-title":"Efficacy and safety of glucagon-like peptide-1 receptor agonists on body weight and cardiometabolic parameters in individuals with obesity and without diabetes: a systematic review and meta-analysis","volume":"30","author":"Ansari","year":"2024","journal-title":"Endocr Pract"},{"issue":"11","key":"2026061602131604300_sjaf244-B44","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1001\/jamasurg.2025.3590","article-title":"Obesity treatment with bariatric surgery vs GLP-1 receptor agonists","volume":"160","author":"Barrett","year":"2025","journal-title":"JAMA Surg"},{"issue":"4","key":"2026061602131604300_sjaf244-B45","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.jse.2024.07.045","article-title":"Does use of glucagon-like peptide-1 agonists increase perioperative complications in patients undergoing shoulder arthroplasty?","volume":"34","author":"Elsabbagh","year":"2025","journal-title":"J Shoulder Elbow Surg"},{"issue":"3","key":"2026061602131604300_sjaf244-B46","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/wjs.12484","article-title":"Impact of preoperative glucagon-like peptide-1 receptor agonist on outcomes following major surgery","volume":"49","author":"Rashid","year":"2025","journal-title":"World J Surg"},{"key":"2026061602131604300_sjaf244-B47","doi-asserted-by":"publisher","first-page":"670155","DOI":"10.3389\/fphar.2021.670155","article-title":"Platelet effects of anti-diabetic therapies: new perspectives in the management of patients with diabetes and cardiovascular disease","volume":"12","author":"Nusca","year":"2021","journal-title":"Front Pharmacol"},{"issue":"7","key":"2026061602131604300_sjaf244-B48","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1111\/dom.16366","article-title":"The effect of GLP-1 receptor agonists on circulating inflammatory markers in type 2 diabetes patients: a systematic review and meta-analysis","volume":"27","author":"Ren","year":"2025","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"2026061602131604300_sjaf244-B49","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1475-2840-13-21","article-title":"Do incretins improve endothelial function?","volume":"13","author":"Oyama","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"2026061602131604300_sjaf244-B50","doi-asserted-by":"publisher","first-page":"114050","DOI":"10.1016\/j.intimp.2025.114050","article-title":"Pro-healing impact of liraglutide on skin wounds in normoglycemic mice","volume":"147","author":"Yue","year":"2025","journal-title":"Int Immunopharmacol"},{"key":"2026061602131604300_sjaf244-B51","doi-asserted-by":"publisher","first-page":"106426","DOI":"10.1016\/j.phrs.2022.106426","article-title":"Glucagon-like peptide 1 and fibroblast growth factor-21 in non-alcoholic steatohepatitis: an experimental to clinical perspective","volume":"184","author":"Yadav","year":"2022","journal-title":"Pharmacol Res"},{"key":"2026061602131604300_sjaf244-B52","doi-asserted-by":"publisher","first-page":"117464","DOI":"10.1016\/j.biopha.2024.117464","article-title":"DPP-IV as a potential candidate in anti-obesity and obesity-related diseases treatment","volume":"180","author":"Guo","year":"2024","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"2026061602131604300_sjaf244-B53","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/prs.0000000000006904","article-title":"Dipeptidyl peptidase-4 inhibitor reduces the risk of developing hypertrophic scars and keloids following median sternotomy in diabetic patients: a nationwide retrospective cohort study using the National Database of Health Insurance Claims of Japan","volume":"146","author":"Suwanai","year":"2020","journal-title":"Plast Reconstr Surg"},{"issue":"4","key":"2026061602131604300_sjaf244-B54","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/sap.0000000000000188","article-title":"Predictive value of nutritional markers for wound healing complications in bariatric patients undergoing panniculectomy","volume":"75","author":"Barbour","year":"2015","journal-title":"Ann Plast Surg"},{"issue":"4","key":"2026061602131604300_sjaf244-B55","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1177\/22925503211019627","article-title":"Negative pressure wound therapy after abdominal body contouring: a comparative matched analysis of outcomes and cost","volume":"30","author":"Morris","year":"2022","journal-title":"Plast Surg"},{"issue":"Supplement_1","key":"2026061602131604300_sjaf244-B56","doi-asserted-by":"publisher","first-page":"ojae007.055","DOI":"10.1093\/asjof\/ojae007.055","article-title":"Aesthetic surgery complications disproportionately burden economically disadvantaged patients and financially strain public health insurance: a single academic center retrospective analysis","volume":"6","author":"Levin","year":"2024","journal-title":"Aesthet Surg J Open Forum"},{"issue":"1","key":"2026061602131604300_sjaf244-B57","doi-asserted-by":"publisher","first-page":"9167","DOI":"10.1038\/s41598-021-88612-x","article-title":"Effects of GLP-1 receptor agonist on changes in the gut bacterium and the underlying mechanisms","volume":"11","author":"Kato","year":"2021","journal-title":"Sci Rep"},{"issue":"6","key":"2026061602131604300_sjaf244-B58","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1001\/jamasurg.2015.5110","article-title":"Prevalence of self-reported symptoms after gastric bypass surgery for obesity","volume":"151","author":"Gribsholt","year":"2016","journal-title":"JAMA Surg"},{"key":"2026061602131604300_sjaf244-B59","doi-asserted-by":"publisher","first-page":"102355","DOI":"10.1016\/j.coph.2023.102355","article-title":"The blood pressure lowering effects of glucagon-like peptide-1 receptor agonists: a mini-review of the potential mechanisms","volume":"69","author":"Ribeiro-Silva","year":"2023","journal-title":"Curr Opin Pharmacol"},{"key":"2026061602131604300_sjaf244-B60","first-page":"171","volume-title":"Effects of GLP-1 and Its Analogs on Gastric Physiology in Diabetes mellitus and Obesity","author":"Maselli","year":"2020"},{"issue":"5","key":"2026061602131604300_sjaf244-B61","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.2337\/db05-1439","article-title":"Regional differences in adipose tissue metabolism in women","volume":"55","author":"Tchernof","year":"2006","journal-title":"Diabetes"},{"issue":"12","key":"2026061602131604300_sjaf244-B62","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1016\/j.numecd.2020.07.010","article-title":"Change in abdominal, but not femoral subcutaneous fat CT-radiodensity is associated with improved metabolic profile after bariatric surgery","volume":"30","author":"Dadson","year":"2020","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"6","key":"2026061602131604300_sjaf244-B63","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1001\/jamasurg.2024.0111","article-title":"Glucagon-like peptide-1 receptor agonist use and residual gastric content before anesthesia","volume":"159","author":"Sen","year":"2024","journal-title":"JAMA Surg"},{"issue":"1","key":"2026061602131604300_sjaf244-B64","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13741-024-00439-y","article-title":"The impact of glucagon-like peptide-1 receptor agonists in the patients undergoing anesthesia or sedation: systematic review and meta-analysis","volume":"13","author":"Do Nascimento","year":"2024","journal-title":"Perioper Med"}],"container-title":["Aesthetic Surgery Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/asj\/advance-article-pdf\/doi\/10.1093\/asj\/sjaf244\/65930645\/sjaf244.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/asj\/article-pdf\/46\/7\/728\/65930645\/sjaf244.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/asj\/article-pdf\/46\/7\/728\/65930645\/sjaf244.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:13:26Z","timestamp":1781590406000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/asj\/article\/46\/7\/728\/8382224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":64,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,12,17]]},"published-print":{"date-parts":[[2026,6,16]]}},"URL":"https:\/\/doi.org\/10.1093\/asj\/sjaf244","relation":{},"ISSN":["1090-820X","1527-330X"],"issn-type":[{"value":"1090-820X","type":"print"},{"value":"1527-330X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2025,12,17]]}}}